To view the PDF file, sign up for a MySharenet subscription.

RENERGEN LIMITED - Renergen IPO Oversubscribed and Appointment of Director

Release Date: 29/05/2019 10:59
Code(s): REN     PDF:  
Wrap Text
Renergen IPO Oversubscribed and Appointment of Director

RENERGEN LIMITED
(Incorporated in the Republic of South Africa)
(Registration number: 2014/195093/06])
Share code: REN
ISIN: ZAE000202610
(“RENERGEN” or “the Company”)

RENERGEN IPO OVERSUBSCRIBED AND APPOINTMENT OF DIRECTOR

    •    Emerging producer of liquid helium and liquefied natural gas, Renergen Limited (Renergen or the
         Company) will commence trading on the Australian Securities Exchange under the ASX Code: RLT
    •    Already listed on Johannesburg’s AltX exchange (under code: REN) Renergen, in its secondary listing,
         raised twice the minimum subscription, closing at $10 million with oversubscriptions
    •    Renergen provides investors with exposure to both natural gas and helium through its proven reserves
         and existing off-take agreements
    •    Renergen possesses the first and only onshore petroleum production right in South Africa
    •    Funds raised under the offer are to be used for further exploration and expansion of the Virginia Gas
         Project, which contains a significant natural gas resource and one of the richest helium concentrations
         globally
    •    Dr David King joins Renergen’s Board on Tuesday, 4 June 2019 as an independent, non-executive
         director.

The announcement follows the completion of an offer of the Company’s securities to investors (Offer), which raised
$10 million with oversubscriptions through the issue of 12,500,000 CDIs at a subscription price of $0.80.
Managing Director and CEO, Stefano Marani, made the following comments in support of the capital raise:

        “Renergen provides to investors a unique exposure to helium; a rare, finite commodity with strong demand
         and supply fundamentals. Renergen owns 90% of Tetra4 Proprietary Limited (Tetra4), the holder of the
         first and only onshore petroleum production right in South Africa, giving it first mover advantage.
         Renergen is developing South Africa’s first commercial LNG project, the Virginia Gas Project, which has
         one of the highest helium concentrations recorded globally. The production right remains valid for a
         further 23 years and is situated in an energy scarce area with high customer density and limited
         competition.
         The most compelling part of our story relates to the quality of our helium resource at a critical time when
         there is diminishing supply of such a strategic resource. Helium is an irreplaceable element with multiple
         applications across cryogenics (MRIs), semi-conductor manufacturing, fibre optics and rocket launches.
         The growing strategic importance of Renergen’s helium production is demonstrated by a commitment of
         US$40 million in debt funding from OPIC, the US Government’s development finance institution, to assist
         the Virginia Gas Project.”

Chairman, Brett Kimber made the following statement:
         “We would like to welcome our new shareholders to the Company. The Company maintains a prominent
          position in the South African LNG and global helium markets through established gas sales agreements
          with the Linde Group, Anheuser-Busch and Black Knight Logistics, operated by its majority owned
          subsidiary, Tetra4.
          I would also like to welcome David King, who joins the Renergen Board as an independent non-executive
          director. David’s pedigree achieved through decades of office in both executive roles and directorships
          in listed oil and gas companies, will result insignificant benefits to shareholders.”

In summary, Renergen provides its shareholders with:

    •      an ASX and JSE AltX listed investment exposure to helium, a rare finite commodity with strong demand
           and supply credentials;
    •      an investment in South Africa’s first commercial LNG project;
    •      expected near-term helium and LNG production;
    •      significant helium and natural gas reserves and resources, maintained under a production right valid for
           a further 23 years; and
    •      access to existing production supplies – Tetra4 is already fully operational and is selling all of its CNG
           production until the LNG plant is commissioned.

Renergen will primarily use the funds raised through this Offer to finance the drilling of additional production wells
in Tetra4’s proven gas reserves, aiming to produce gas to operate the New Plant established at the Virginia Gas
Project at maximum capacity. The raise will also fund a feasibility study for the commercialisation of the high
concentration helium reserves contained in the Virginia Gas Project’s prospective sandstone deposit.

APPOINTMENT OF DIRECTOR

In accordance with paragraph 3.59(b) of the JSE Limited Listings Requirements, the board of directors of the
Company wishes to advise that Dr David King will be appointed as an independent, non-executive director of the
Company effective from 4 June 2019.
Dr King previously held office as director of Sapex Ltd, Gas2Grid Ltd and Eastern Star Gas Ltd, companies that
he also founded. He holds an MSc in Geophysics from the Imperial College, London, and a PhD in Seismology
from the Australian National University, Canberra. He has substantial natural resource related experience.

The board welcomes Dr King and looks forward to his contribution to the Company.

- Ends -
For Media or Investor Inquiries:
Peter Brookes, Citadel-MAGNUS
+61 (0) 407 911 389

29 May 2019

Designated Adviser
PSG Capital

Date: 29/05/2019 10:59:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Share This Story